FRCPath Haem Part 1 MCQ-Oncology 26

Which of the following best describes the current BSH recommendation for CNS prophylaxis in DLBCL?

• Intrathecal methotrexate for all patients
• High-dose intravenous methotrexate in high-risk cases
• Intrathecal cytarabine in all elderly patients
• No CNS prophylaxis is ever recommended

See All Options